CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
238.66B
DBALX
Price
$13.15
Change
+$0.05 (+0.38%)
Updated
Jan 17 closing price
Net Assets
239.14M
Ad is loading...

CLBCX vs DBALX

Header iconCLBCX vs DBALX Comparison
Open Charts CLBCX vs DBALXBanner chart's image
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets238.66B
Davenport Balanced Income
Price$13.15
Change+$0.05 (+0.38%)
VolumeN/A
Net Assets239.14M
CLBCX vs DBALX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. DBALX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and DBALX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 239B vs. DBALX (239M). DBALX pays higher dividends than CLBCX: DBALX (2.25) vs CLBCX (1.52). CLBCX was incepted earlier than DBALX: CLBCX (23 years) vs DBALX (9 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. DBALX (24.00). CLBCX has a lower initial minimum investment than DBALX: CLBCX (250) vs DBALX (5000). CLBCX annual gain was more profitable for investors over the last year : 11.42 vs. DBALX (9.57). CLBCX return over 5 years is better than : 26.62 vs. DBALX (17.84).
CLBCXDBALXCLBCX / DBALX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD1.8941.388136%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets239B239M100,000%
Annual Yield % from dividends1.522.2568%
Returns for 1 year11.429.57119%
Returns for 3 years11.241.96573%
Returns for 5 years26.6217.84149%
Returns for 10 years56.78N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin